Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia

被引:46
作者
Takenoshita, H
Shizuka-Ikeda, M
Mitoma, H
Song, SY
Harigaya, Y
Igeta, Y
Yaguchi, M
Ishida, K
Shoji, M
Tanaka, M
Mizusawa, H
Okamoto, K
机构
[1] Gunma Univ, Sch Med, Dept Neurol, Gunma 3718511, Japan
[2] Mitsubishi Kasei Inst Life Sci, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Tokyo, Japan
关键词
GAD autoantibodies; parch clamp; cerebellar ataxia;
D O I
10.1136/jnnp.70.3.386
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autoantibodies against glutamic acid decarboxylase (GAD) have been found in stiff-man syndrome, insulin dependent diabetes mellitus, and progressive cerebellar ataxia. A patient with progressive cerebellar ataxia is described who was positive for GAD autoantibodies, and had Sjogren's syndrome. Immunohistochemical studies using CSF and serum samples from the patient showed immunoreactivities in axon terminals of cerebellar GABAergic neurons. A whole cell patch clamp technique recording from rat cerebellar slices showed that the CSF, presumably through GAD autoantibodies, presynaptically inhibited GABAergic transmission. Intravenous administration of immunoglobulin failed to improve clinical symptoms and immunoreactivities examined after therapy. The findings suggest that GAD autoantibodies play a pathogenic part in reducing GABA release in in vitro slices.
引用
收藏
页码:386 / 389
页数:4
相关论文
共 15 条
[1]   Cerebellar ataxia with glutamic acid decarboxylase autoantibodies [J].
Abele, M ;
Weller, M ;
Mescheriakov, S ;
Bürk, K ;
Dichgans, J ;
Klockgether, T .
NEUROLOGY, 1999, 52 (04) :857-859
[2]   SJOGREN SYNDROME - CENTRAL NERVOUS-SYSTEM MANIFESTATIONS [J].
ALEXANDER, GE ;
PROVOST, TT ;
STEVENS, MB ;
ALEXANDER, EL .
NEUROLOGY, 1981, 31 (11) :1391-1396
[3]   TREATMENT OF STIFF-MAN SYNDROME WITH INTRAVENOUS IMMUNOGLOBULIN [J].
AMATO, AA ;
CORNMAN, EW ;
KISSEL, JT .
NEUROLOGY, 1994, 44 (09) :1652-1654
[4]   Successful treatment of stiff man syndrome with intravenous immunoglobulin [J].
Barker, RA ;
Marsden, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04) :426-427
[5]   Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases [J].
Dalakas, MC .
NEUROLOGY, 1998, 51 (06) :S2-S8
[6]   Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome [J].
Dinkel, K ;
Meinck, HM ;
Jury, KM ;
Karges, W ;
Richter, W .
ANNALS OF NEUROLOGY, 1998, 44 (02) :194-201
[7]   The clinical significance of an autoimmune response against glutamic acid decarboxylase [J].
Ellis, TM ;
Atkinson, MA .
NATURE MEDICINE, 1996, 2 (02) :148-153
[8]   Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia [J].
Giometto, B ;
Miotto, D ;
Faresin, F ;
Argentiero, V ;
Scaravilli, T ;
Tavolato, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :57-59
[9]  
Ishida K, 1999, ANN NEUROL, V46, P263, DOI 10.1002/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO
[10]  
2-0